StonvexLoading…
StonvexStonvexStonvexCore line items from CELH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.52B | $1.36B | $1.32B | $653.60M |
Operating Income | $141.06M | $155.73M | $266.37M | $-157.80M |
Net Income | $108.00M | $145.07M | $226.80M | $-187.28M |
EPS (Diluted) | $0.25 | $0.45 | $0.77 | $-0.88 |
Total Assets | $5.12B | $1.77B | $1.54B | $1.22B |
Total Liabilities | $2.18B | $542.46M | $447.87M | $357.49M |
Cash & Equivalents | $398.87M | $890.19M | $755.98M | $614.16M |
Free Cash Flow OCF − CapEx | $323.38M | $239.51M | $123.78M | $99.92M |
Shares Outstanding | 256.91M | 235.01M | 231.79M | 229.15M |